Responsive-released strategy based on lead ions-dependent DNAzyme functionalized UIO-66-NH2 for tumor marker

Tunable metal-organic frameworks assist in catalyzing DNAzymes with amplification platforms for biomedical applications

Various binding modes of tunable metal organic frameworks (MOFs) and functional DNAzymes (Dzs) synergistically catalyze the emergence of abundant functional nanoplatforms. Given their serial variability in formation, structural designability, and functional controllability, Dzs@MOFs tend to be excellent building blocks for the precise "intelligent" manufacture of functional materials. To present a clear outline of this new field, this review systematically summarizes the progress of Dz integration into MOFs (MOFs@Dzs) through different methods, including various surface infiltration, pore encapsulation, covalent binding, and biomimetic mineralization methods. Atomic-level and time-resolved catalytic mechanisms for biosensing and imaging are made possible by the complex interplay of the distinct molecular structure of Dzs@MOF, conformational flexibility, and dynamic regulation of metal ions. Exploiting the precision of DNAzymes, MOFs@Dzs constructed a combined nanotherapy platform to guide intracellular drug synthesis, photodynamic therapy, catalytic therapy, and immunotherapy to enhance gene therapy in different ways, solving the problems of intracellular delivery inefficiency and insufficient supply of cofactors. MOFs@Dzs nanostructures have become excellent candidates for biosensing, bioimaging, amplification delivery, and targeted cancer gene therapy while emphasizing major advancements and seminal endeavors in the fields of biosensing (nucleic acid, protein, enzyme activity, small molecules, and cancer cells), biological imaging, and targeted cancer gene delivery and gene therapy. Overall, based on the results demonstrated to date, we discuss the challenges that the emerging MOFs@Dzs might encounter in practical future applications and briefly look forward to their bright prospects in other fields.

Competitive photoelectrochemical aptamer sensor based on a Z-scheme Fe2O3/g-C3N4 heterojunction for sensitive detection of lead ions

Lead ion (Pb2+) is one of the heavy metal contaminants within the environment, which can seriously affect biological health. Thus, it is very important to detect lead ions, especially exceeding the standard concentration (100 ng/mL). In this work, we have developed a photoelectrochemical (PEC) aptamer sensor with Z-scheme Fe2O3/g-C3N4 heterojunction as a substrate material for sensitive detection of Pb2+. Specifically, Fe2O3/g-C3N4 is employed as a substrate with a powerful and stable photocurrent response. Au and DNA-1 connected to the substrate material via the Au-S bond and increased the electron conduction. Marking DNA-2 with ZnO effectively reduced the light absorption intensity resulting in a lower photocurrent response. Surprisingly, the Pb2+ PEC sensor showed good linearity in the detection range of 62 pg/mL to 1 μg/mL with a detection limit as low as 7.9 pg/mL (S/N = 3). The sensor showed stable recovery and low relative standard deviation in real sample detection. Additionally, the sensor exhibited excellent stability, selectivity, and reproducibility. The reproducibility of the electrodes was evaluated, and the accuracy of the individual electrode current values was calculated to range from 0.5% to 2.71% with an RSD of 1.74%. Such PEC sensor guarantees to supply a brand-new approach to the detection of Pb2+.

Homogeneous voltammetric sensing strategy for lead ions based on aptamer gated methylthionine chloride@UiO-66-NH2 framework as smart target-stimulated responsive nanomaterial

Herein an innovative electrochemical method is proposed for the determination of lead ions (Pb²⁺) based on a homogeneous voltammetric (HVC) sensing strategy using an aptamer gated methylthionine chloride@UiO-66-NH₂ framework as a smart target-stimulated responsive material. The proposed HVC sensor exhibits excellent sensing performance: ultralow detection limit (0.166 pM) and wide linearity (5.0 pM-500.0 nM), simultaneously, it avoids electrodeposition processes and it is simple to modify the electrode compared to previous electrochemical methods for Pb²⁺ detection. Thus our method shows great potential in the highly efficient detection of Pb²⁺ and other heavy metal ions by simply altering the related specific aptamer.

DNA walker-amplified signal-on electrochemical aptasensors for prostate-specific antigen coupling with two hairpin DNA probe-based hybridization reaction

Electrochemical aptasensing systems have been developed for screening low-abundance disease-related proteins, but most of them involve multiple washings and multi-step separation during measurements, and thus are disadvantageous for routine use. In this work, an innovative and simple electrochemical aptasensing platform was designed for the voltammetric detection of prostate-specific antigen (PSA) in biological fluids without any washing and separation steps. This system mainly included a PSA-specific aptamer, a DNA walker and two hairpin DNA probes (i.e., thiolated hairpin DNA1 and ferrocene-labeled hairpin DNA2). Introduction of target PSA caused the release of the DNA walker from a partially complementary aptamer/DNA walker hybridization strand. The dissociated DNA walker opened the immobilized hairpin DNA1 on the electrode, accompanying subsequent displacement reaction with hairpin DNA2, thus resulting in the DNA walker step-by-step reaction with numerous hairpin DNA1 probes on the sensing interface. In this case, numerous ferrocene molecules were close to the electrode to amplify the voltammetric signal within the applied potentials. All reactions and electrochemical measurements including the target/aptamer reaction and hybridization chain reaction were implemented in the same detection cell. Under optimal conditions, the fabricated electrochemical aptasensor gave good voltammetric responses relative to the PSA concentrations within the range of 0.001-10 ng mL^-1 at an ultralow detection limit of 0.67 pg mL^-1. A good reproducibility with batch-to-batch errors was acquired for target PSA down to 11.5%. Non-target analytes did not interfere with the voltammetric signals of the electrochemical aptasensors. Meanwhile, 15 human serum specimens were measured with electrochemical aptasensors, and displayed well-matched results in comparison with the referenced human PSA enzyme-linked immunosorbant assay (ELISA) method. Significantly, this method provides a new horizon for the quantitative monitoring of low-concentration biomarkers or nucleic acids.

Target-modulated competitive binding and exonuclease I-powered strategy for the simultaneous and rapid detection of biological targets

Simultaneous multiple-target detection is essential for the prevention, identification, and treatment of numerous diseases. In this study, a novel strategy based on target-modulated competitive binding and exonuclease I (Exo I)-powered signal molecule release was established with the advantages of rapid response and high selectivity and sensitivity. The strategy holds substantial potential for the development of versatile platforms for the simultaneous detection of biological targets. To mitigate the low load capacity and time-consuming responsive process of the Zr-MOF system, UiO-67 was chosen to replace UiO-66 (a typical Zr-MOF) as the nanocarrier for encapsulating more signal molecules, whereby the assembled double-stranded DNA (dsDNA) structures of UiO-67 acted as gatekeepers to form dsDNA-functionalized MOFs. Additionally, Exo I was introduced into the system to accelerate the release of the signal molecules. In the presence of biological targets, the competitive binding between the targets and aptamers caused the hydrolysis of the free DNA sequence by Exo I, promoting the release of signal molecules and leading to a rapid and significant increase in the fluorescence intensity. For adenosine triphosphate (ATP) and cytochrome c (cyt c), which were chosen as model biological targets, this sensor displayed detection limits as low as 5.03 and 6.11 fM, respectively. Moreover, the developed biosensor was successfully applied to the simultaneous detection of ATP and cyt c in spiked serum samples. Therefore, this strategy provides guidance for further research of biosensors for simultaneous multiple-target detection and propels the application of MOF carriers in biomedicine.